Home  /  Resource Library  /  Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study

Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study

Results of a phase III study investigating romidepsin in combination with chemotherapy for first line treatment of peripheral t-cell lymphomas.